187 related articles for article (PubMed ID: 20955350)
1. Loss of Klotho during melanoma progression leads to increased filamin cleavage, increased Wnt5A expression, and enhanced melanoma cell motility.
Camilli TC; Xu M; O'Connell MP; Chien B; Frank BP; Subaran S; Indig FE; Morin PJ; Hewitt SM; Weeraratna AT
Pigment Cell Melanoma Res; 2011 Feb; 24(1):175-86. PubMed ID: 20955350
[TBL] [Abstract][Full Text] [Related]
2. Wnt5A activates the calpain-mediated cleavage of filamin A.
O'Connell MP; Fiori JL; Baugher KM; Indig FE; French AD; Camilli TC; Frank BP; Earley R; Hoek KS; Hasskamp JH; Elias EG; Taub DD; Bernier M; Weeraratna AT
J Invest Dermatol; 2009 Jul; 129(7):1782-9. PubMed ID: 19177143
[TBL] [Abstract][Full Text] [Related]
3. Heparan sulfate proteoglycan modulation of Wnt5A signal transduction in metastatic melanoma cells.
O'Connell MP; Fiori JL; Kershner EK; Frank BP; Indig FE; Taub DD; Hoek KS; Weeraratna AT
J Biol Chem; 2009 Oct; 284(42):28704-12. PubMed ID: 19696445
[TBL] [Abstract][Full Text] [Related]
4. The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma.
O'Connell MP; Fiori JL; Xu M; Carter AD; Frank BP; Camilli TC; French AD; Dissanayake SK; Indig FE; Bernier M; Taub DD; Hewitt SM; Weeraratna AT
Oncogene; 2010 Jan; 29(1):34-44. PubMed ID: 19802008
[TBL] [Abstract][Full Text] [Related]
5. WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells.
Ekström EJ; Bergenfelz C; von Bülow V; Serifler F; Carlemalm E; Jönsson G; Andersson T; Leandersson K
Mol Cancer; 2014 Apr; 13():88. PubMed ID: 24766647
[TBL] [Abstract][Full Text] [Related]
6. The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition.
Dissanayake SK; Wade M; Johnson CE; O'Connell MP; Leotlela PD; French AD; Shah KV; Hewitt KJ; Rosenthal DT; Indig FE; Jiang Y; Nickoloff BJ; Taub DD; Trent JM; Moon RT; Bittner M; Weeraratna AT
J Biol Chem; 2007 Jun; 282(23):17259-71. PubMed ID: 17426020
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Age-Related Therapy Resistance in Melanoma by Rosiglitazone-Mediated Induction of Klotho.
Behera R; Kaur A; Webster MR; Kim S; Ndoye A; Kugel CH; Alicea GM; Wang J; Ghosh K; Cheng P; Lisanti S; Marchbank K; Dang V; Levesque M; Dummer R; Xu X; Herlyn M; Aplin AE; Roesch A; Caino C; Altieri DC; Weeraratna AT
Clin Cancer Res; 2017 Jun; 23(12):3181-3190. PubMed ID: 28232477
[No Abstract] [Full Text] [Related]
8. A t-butyloxycarbonyl-modified Wnt5a-derived hexapeptide functions as a potent antagonist of Wnt5a-dependent melanoma cell invasion.
Jenei V; Sherwood V; Howlin J; Linnskog R; Säfholm A; Axelsson L; Andersson T
Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19473-8. PubMed ID: 19901340
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 drives melanoma cell motility through p38α-MAPK-dependent up-regulation of WNT5A expression.
Linnskog R; Jönsson G; Axelsson L; Prasad CP; Andersson T
Mol Oncol; 2014 Dec; 8(8):1365-78. PubMed ID: 24954857
[TBL] [Abstract][Full Text] [Related]
10. Receptor tyrosine kinase Ror2 mediates Wnt5a-induced polarized cell migration by activating c-Jun N-terminal kinase via actin-binding protein filamin A.
Nomachi A; Nishita M; Inaba D; Enomoto M; Hamasaki M; Minami Y
J Biol Chem; 2008 Oct; 283(41):27973-27981. PubMed ID: 18667433
[TBL] [Abstract][Full Text] [Related]
11. Methylation and loss of Secreted Frizzled-Related Protein 3 enhances melanoma cell migration and invasion.
Ekström EJ; Sherwood V; Andersson T
PLoS One; 2011 Apr; 6(4):e18674. PubMed ID: 21494614
[TBL] [Abstract][Full Text] [Related]
12. WNT5A expression increases during melanoma progression and correlates with outcome.
Da Forno PD; Pringle JH; Hutchinson P; Osborn J; Huang Q; Potter L; Hancox RA; Fletcher A; Saldanha GS
Clin Cancer Res; 2008 Sep; 14(18):5825-32. PubMed ID: 18794093
[TBL] [Abstract][Full Text] [Related]
13. Regulation of prostate cancer cell migration toward bone marrow stromal cell-conditioned medium by Wnt5a signaling.
Jin F; Qu X; Fan Q; Wang L; Tang T; Hao Y; Dai K
Mol Med Rep; 2013 Nov; 8(5):1486-92. PubMed ID: 24064566
[TBL] [Abstract][Full Text] [Related]
14. Phenylmethimazole decreases Toll-like receptor 3 and noncanonical Wnt5a expression in pancreatic cancer and melanoma together with tumor cell growth and migration.
Schwartz AL; Malgor R; Dickerson E; Weeraratna AT; Slominski A; Wortsman J; Harii N; Kohn AD; Moon RT; Schwartz FL; Goetz DJ; Kohn LD; McCall KD
Clin Cancer Res; 2009 Jun; 15(12):4114-22. PubMed ID: 19470740
[TBL] [Abstract][Full Text] [Related]
15. [Preparation of the recombinant lentiviral expression vector targeting human Wnt5a gene and its inhibitory effect on melanoma cell invasion].
Zhao Y; Miao Y; Chen X; Wang L; Lu F; Liao W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 May; 30(5):462-5. PubMed ID: 24796738
[TBL] [Abstract][Full Text] [Related]
16. Filopodia formation mediated by receptor tyrosine kinase Ror2 is required for Wnt5a-induced cell migration.
Nishita M; Yoo SK; Nomachi A; Kani S; Sougawa N; Ohta Y; Takada S; Kikuchi A; Minami Y
J Cell Biol; 2006 Nov; 175(4):555-62. PubMed ID: 17101698
[TBL] [Abstract][Full Text] [Related]
17. Wnt5a suppresses colon cancer by inhibiting cell proliferation and epithelial-mesenchymal transition.
Cheng R; Sun B; Liu Z; Zhao X; Qi L; Li Y; Gu Q
J Cell Physiol; 2014 Dec; 229(12):1908-17. PubMed ID: 24464650
[TBL] [Abstract][Full Text] [Related]
18. Wnt5A regulates expression of tumor-associated antigens in melanoma via changes in signal transducers and activators of transcription 3 phosphorylation.
Dissanayake SK; Olkhanud PB; O'Connell MP; Carter A; French AD; Camilli TC; Emeche CD; Hewitt KJ; Rosenthal DT; Leotlela PD; Wade MS; Yang SW; Brant L; Nickoloff BJ; Messina JL; Biragyn A; Hoek KS; Taub DD; Longo DL; Sondak VK; Hewitt SM; Weeraratna AT
Cancer Res; 2008 Dec; 68(24):10205-14. PubMed ID: 19074888
[TBL] [Abstract][Full Text] [Related]
19. Assaying Wnt5A-mediated invasion in melanoma cells.
O'Connell MP; French AD; Leotlela PD; Weeraratna AT
Methods Mol Biol; 2008; 468():243-53. PubMed ID: 19099260
[TBL] [Abstract][Full Text] [Related]
20. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma.
Weeraratna AT; Jiang Y; Hostetter G; Rosenblatt K; Duray P; Bittner M; Trent JM
Cancer Cell; 2002 Apr; 1(3):279-88. PubMed ID: 12086864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
